Comparing trastuzumab-resistant (SKTR) and trastuzumab-sensitive (SK) HER2+ human breast cancer cell models, IRX6 was found to be a differentially methylated and differentially expressed gene, indicating a potential role in trastuzumab resistance [75]. Here, IRX6 is linked to breast carcinoma.